Garcia Hamilton & Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,088
Closed -$412K 17
2017
Q3
$412K Sell
5,088
-10,204
-67% -$780K 1.07% 22
2017
Q2
$1.08M Sell
15,292
-10,320
-40% -$687K 1.5% 16
2017
Q1
$1.76M Sell
25,612
-19,353
-43% -$1.36M 1.55% 18
2016
Q4
$3.22M Sell
44,965
-2,300
-5% -$171K 1.86% 17
2016
Q3
$3.74M Buy
47,265
+2,666
+6% +$217K 2.2% 17
2016
Q2
$3.72M Buy
44,599
+3,533
+9% +$314K 2.24% 15
2016
Q1
$3.77M Buy
41,066
+14,291
+53% +$1.29M 2.19% 15
2015
Q4
$2.71M Buy
26,775
+1,216
+5% +$127K 1.59% 26
2015
Q3
$2.51M Sell
25,559
-1,021
-4% -$113K 1.54% 27
2015
Q2
$3.11M Sell
26,580
-3,626
-12% -$396K 1.73% 23
2015
Q1
$2.96M Sell
30,206
-8,348
-22% -$848K 1.45% 31
2014
Q4
$3.63M Sell
38,554
-28,682
-43% -$2.97M 1.41% 31
2014
Q3
$7.16M Sell
67,236
-17,300
-20% -$1.69M 2.08% 17
2014
Q2
$7.01M Sell
84,536
-2,465
-3% -$192K 1.64% 25
2014
Q1
$6.17M Buy
+87,001
New +$6.82M 1.45% 34

Other funds holding GILD

Garcia Hamilton & Associates's GILD Position: Q4 2017 in Review

Garcia Hamilton & Associates sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 5,088 shares — an estimated $412K sold.

Garcia Hamilton & Associates first reported a position in GILD in Q1 2014 and held it in 15 quarters. The position peaked at $7.16M in Q3 2014. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Garcia Hamilton & Associates reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
  • Garcia Hamilton & Associates sold 5,088 Gilead Sciences shares in Q4 2017, an estimated $412K.
  • Garcia Hamilton & Associates first reported a position in Gilead Sciences in Q1 2014 and held it in 15 quarters.
  • Garcia Hamilton & Associates's Gilead Sciences position peaked at $7.16M in Q3 2014.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2017, filed 19 Jan 2018.